Report Scope & Overview:
The Healthcare CRM Market Size was valued at USD 12.14 billion in 2022, and is expected to reach USD 23.14 billion by 2030, and grow at a CAGR of 8.4% over the forecast period 2023-2030.
Healthcare Customer Relationship Management (CRM) is a system that aids healthcare businesses in having more effective workflow and better management of the patient care process. Technology employed in the healthcare CRM system includes collaborative system, cloud-based CRM, mobile CRM, social CRM, and predictive CRM. CRM for healthcare boosts service delivery effectiveness and communication. Patients' information is gathered from a variety of sources using the healthcare CRM. By using feedback forms, online forms, and services for various firms, it enhances sales and marketing efforts. By automating tasks like sending emails and texts and communicating test results, healthcare facilities can benefit from healthcare CRM technology.
To get more information on Healthcare CRM Market - Request Sample Report
Since many healthcare facilities are concentrating on direct marketing to build their businesses, the healthcare CRM market is predicted to experience a lucrative growth throughout the forecast period. Additionally, the development of the worldwide CRM market is anticipated to be hampered by the developing countries' limited or absent adoption of healthcare CRM.
Gains from CRM Software
Increasing Attention to Patient Engagement
Privacy and Data Security Issues
Implementing CRM is expensive and difficult.
CRM using AI
Analytics for the future in CRM
Lacking healthcare professionals
IMPACT OF COVID-19
The COVID-19 pandemic outbreak had a significant effect on medical facilities. An integrated solution was desperately needed to manage workflow and provide help and care to patients effectively around the globe. The IT sector of healthcare has been primarily impacted by the use of data, analytical, and digitalization technology. The COVID-19 epidemic has compelled market participants to concentrate on R&D for advancements and improvements in the Healthcare CRM industry.
VALUE CHAIN ANALYSIS
During the anticipated period, the market is anticipated to be dominated by the growing use of CRM systems in the healthcare and healthcare provider sectors. The proliferation of the healthcare CRM market will also be aided by the existence of numerous insurance firms. Additionally, the market will likely be driven during the projected period by market players' quick development and introduction, which are mostly employed to improve marketing and sales procedures among pharmaceutical and biotechnology firms.
The CRM category for individuals and referrals has the highest revenue share. Due to a rising demand, referral healthcare is anticipated to experience the quickest growth during the projection period. Due to shifting business models and the ongoing demand for integration between patients, providers, and payers, individuals and referrals are anticipated to obtain the largest share during the projected period. The transition from volume to value-based treatment is anticipated to propel the expansion of the referral CRM market. CRM for personal healthcare is anticipated to benefit from horizontal and vertical consolidation among hospitals and independent providers.
The market leader and contributor to the biggest revenue share was the community outreach sector. The increasing adoption of healthcare CRM solutions for this application is responsible for the segment's expansion. The sector is further divided into three categories: managing financial donors, service marketing and outreach, and community health education. Due to automation and centralization in the healthcare industry, case coordination is predicted to experience profitable growth. Pre-authorizations/eligibility, referrals, and other categories are added to the segment's further classification.
A growing number of chronic diseases and behavioural health issues are predicted to lead to significant growth in the case management market. The sector is further divided into two categories: managing chronic diseases and managing relationships with clinical trials.
The market was dominated by cloud-based technology, which also accounted for the biggest revenue share. Due to rising consumerism and potential patient empowerment, the social sector is also anticipated to experience significant growth. Due to its increased popularity among doctors, pharmaceutical companies, and patients, the mobile customer relationship management category is anticipated to have the quickest growth throughout the course of the projection period. Due to the increasing popularity of home and virtual care, predictive analysis is also anticipated to increase. The demand for integrated care, care management, and care coordination is anticipated to drive the expansion of the collaborative CRM market.
The biggest revenue share was contributed by the payer category, which controlled the healthcare CRM industry. Payers include insurance providers, while providers include hospitals, clinics, and a range of specialist facilities like hospice care and long-term care facilities, as well as life sciences firms like pharmaceutical and biotechnology firms as well as Clinical Research Organizations (CROs).
During the forecast period, the use of the products in the field of life science is anticipated to rise most quickly. This is due to life sciences organisations growing use of healthcare CRM software. Because hospitals and clinics are increasingly using these solutions for patient management and appointment scheduling procedures, the provider's segment is also anticipated to experience profitable growth over the course of the projection year.
KEY MARKET SEGMENTS:
Individual healthcare CRM
Referral healthcare CRM
Individual and referral healthcare CRM
Need any customization research on Healthcare CRM Market - Enquiry Now
The American Region, Asia-Pacific, Europe, the Middle East, and the rest of the globe are the geographical divisions of the worldwide healthcare CRM market. The region of South America and North America has dominated the market. because the market has been backed by payers, hospitals, and early adoption of the healthcare CRM system.
A considerable portion of the market was accounted for by Europe. This significant increase is attributed to the companies' primary focus on infrastructure, investments in research and development, and developed economies.
In the worldwide healthcare CRM market, the Asia-Pacific region is predicted to grow at the quickest rate. One of the key drivers is the rising number of investors in the healthcare industry, particularly in private hospitals. Due to government initiatives and the growing infrastructure of the healthcare CRM system, the healthcare CRM market is anticipated to grow gradually and steadily across the rest of the world.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
Some of the major key players are as follows: Cerner Corporation, Microsoft Corporation, Sage Group Plc, Oracle Corporation, Keona Health., SAP SE, Pegasystems Inc, Salesforce.Com Inc, Zoho Corporation Pvt Ltd, SugarCRM, and other players.
Sage Group Plc-Company Financial Analysis
|Market Size in 2022||US$ 12.14 Billion|
|Market Size by 2030||US$ 23.14 Billion|
|CAGR||CAGR of 8.4% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product (Individual healthcare CRM, Referral healthcare CRM, Individual and referral healthcare CRM)
• By Application (Community outreach, Case coordination, Case management, Relationship management)
• By Technology (Cloud-based, Mobile, Social, Collaborative, Predictive)
• By End-use (Payers, Providers, Life Sciences)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Cerner Corporation, Microsoft Corporation, Sage Group Plc, Oracle Corporation, Keona Health., SAP SE, Pegasystems Inc, Salesforce.Com Inc, Zoho Corporation Pvt Ltd, SugarCRM, and other players.|
|DRIVERS||• Gains from CRM Software
• Increasing Attention to Patient Engagement
|RESTRAINTS||• Privacy and Data Security Issues
• Implementing CRM is expensive and difficult.
Healthcare CRM Market Size was valued at USD 12.14 billion in 2022.
Ans: The Healthcare CRM Market is to grow at a CAGR of 8.4% during the forecast period 2023-2030.
Cerner Corporation, Microsoft Corporation, Sage Group Plc, Oracle Corporation, Keona Health., SAP SE are the key players of Healthcare CRM market
The region of South America and North America has dominated the market.
Gains from CRM Software, Increasing Attention to Patient Engagement are the key drivers of the Healthcare CRM market
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
188.8.131.52 United Kingdom
184.108.40.206 South Korea
220.127.116.11 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Healthcare CRM Market Segmentation, By Product
8.1 Individual healthcare CRM
8.2 Referral healthcare CRM
8.3 Individual and referral healthcare CRM
9. Healthcare CRM Market Segmentation, By Application
9.1 Community outreach
9.2 Case coordination
9.3 Case management
9.4 Relationship management
10. Healthcare CRM Market Segmentation, By Technology
10. 5 Predictive
11. Healthcare CRM Market Segmentation, By End-use
11. 3Life Sciences
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13.1 Cerner Corporation
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Microsoft Corporation
13.3 Sage Group Plc
13.4 Oracle Corporation
13.5 Keona Health.
13.6 SAP SE
13.7 Pegasystems Inc
13.8 Salesforce.Com Inc
13.9 Zoho Corporation Pvt Ltd
14. Competitive landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare Market size was estimated USD 19,507 billion in 2022 and is expected to reach USD 38,021 billion by 2030 at a CAGR of 8.7% during the forecast period of 2023-2030.
The Active Pharmaceutical Ingredient [API] Market size is expected to reach USD 347.92 billion by 2030, and its Size was valued at USD 211.81 billion in 2022, and grow at a CAGR of 6.4 % over the forecast period 2023-2030.
The Robotic Surgical Procedures Market size was USD 7.09 Billion in 2022 and is expected to Reach USD 33.89 Billion by 2030 and grow at a CAGR of 21.6 % over the forecast period of 2023-2030.
The Digital Clinical Trials Market was valued at USD 7.94 billion in 2022 and is expected to reach at USD 12.56 billion in 2030, and grow at a CAGR of 5.9% over the forecast period of 2023-2030.
The Protein Crystallization Market size was estimated USD 1.2 billion in 2022 and is expected to reach USD 2.2 billion by 2030 at a CAGR of 8.3% during the forecast period of 2023-2030.
The Microfluidics Market size was estimated USD 28,718 million in 2022 and is expected to reach USD 72,126 million by 2030 at a CAGR of 12.2% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone